Standard BioTools Inc.
LAB | undefined
-
At close: undefined
-
After-hours:
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 85.33M | 174.43M | 106.34M | 97.95M | 130.58M | 138.14M |
Cost of Revenue | 42.79M | 90.17M | 55.89M | 60.9M | 61.21M | 54.82M |
Gross Profit | 42.54M | 84.26M | 50.45M | 37.05M | 69.37M | 83.33M |
Operating Income | -93.31M | -175.24M | -76.6M | -116.21M | -67.46M | -51.04M |
Interest Income | 9.18M | 20.2M | 5.57M | 2.23M | n/a | n/a |
Pretax Income | -96.7M | -138.31M | -74.2M | -192.93M | -63.66M | -54.1M |
Net Income | -74.9M | -138.89M | -74.66M | -190.1M | -59.24M | -53.02M |
Selling & General & Admin | 109.86M | 156.61M | 87.54M | 102.29M | 98.89M | 97.9M |
Research & Development | 25.99M | 62.41M | 25.95M | 37.38M | 37.94M | 36.46M |
Other Expenses | n/a | 40.48M | 13.56M | 13.59M | n/a | n/a |
Operating Expenses | 135.85M | 259.5M | 127.05M | 153.26M | 136.83M | 134.36M |
Interest Expense | 26K | 3.32M | 4.57M | 4.33M | 3.82M | 3.57M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 178.64M | 349.67M | 182.94M | 214.15M | 198.04M | 189.18M |
Income Tax Expense | -37.88M | 573K | 452K | -2.83M | -4.42M | -1.08M |
Shares Outstanding (Basic) | 381.62M | 352.67M | 79.16M | 78.31M | 75.79M | 72.04M |
Shares Outstanding (Diluted) | 381.62M | 352.67M | 79.16M | 78.31M | 75.79M | 72.04M |
EPS (Basic) | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 |
EPS (Diluted) | -0.20 | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 |
EBITDA | -89.69M | -118.14M | -54.46M | -173.57M | -44.27M | -34.61M |
EBIT | -96.68M | -135M | -69.64M | -188.6M | -59.84M | -50.53M |
Depreciation & Amortization | 6.98M | 16.86M | 15.18M | 15.03M | 15.57M | 15.92M |
Add to Watchlist
Select watchlists to add or remove LAB